Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1958 1
1961 2
1963 1
1964 5
1966 3
1967 3
1968 2
1969 4
1970 1
1973 1
1974 3
1975 1
1976 3
1977 2
1978 1
1979 1
1980 3
1981 1
1982 4
1983 5
1984 3
1985 2
1986 8
1987 8
1988 7
1989 6
1990 3
1991 10
1992 4
1993 16
1994 20
1995 11
1996 22
1997 18
1998 28
1999 20
2000 48
2001 48
2002 44
2003 64
2004 53
2005 66
2006 87
2007 104
2008 107
2009 104
2010 137
2011 155
2012 132
2013 151
2014 142
2015 160
2016 175
2017 189
2018 152
2019 171
2020 198
2021 216
2022 195
2023 178
2024 132

Text availability

Article attribute

Article type

Publication date

Search Results

3,076 results

Results by year

Filters applied: . Clear all
Page 1
Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma.
Motzer RJ, McDermott DF, Escudier B, Burotto M, Choueiri TK, Hammers HJ, Barthélémy P, Plimack ER, Porta C, George S, Powles T, Donskov F, Gurney H, Kollmannsberger CK, Grimm MO, Barrios C, Tomita Y, Castellano D, Grünwald V, Rini BI, McHenry MB, Lee CW, McCarthy J, Ejzykowicz F, Tannir NM. Motzer RJ, et al. Among authors: lee cw. Cancer. 2022 Jun 1;128(11):2085-2097. doi: 10.1002/cncr.34180. Epub 2022 Apr 5. Cancer. 2022. PMID: 35383908 Free PMC article. Clinical Trial.
Galectin-3 aggravates microglial activation and tau transmission in tauopathy.
Siew JJ, Chen HM, Chiu FL, Lee CW, Chang YM, Chen HL, Nguyen TNA, Liao HT, Liu M, Hagar HT, Sun YC, Lai HL, Kuo MH, Blum D, Buée L, Jin LW, Chen SY, Ko TM, Huang JR, Kuo HC, Liu FT, Chern Y. Siew JJ, et al. Among authors: lee cw. J Clin Invest. 2024 Jan 16;134(2):e165523. doi: 10.1172/JCI165523. J Clin Invest. 2024. PMID: 37988169 Free PMC article.
First-line Nivolumab plus Ipilimumab Versus Sunitinib in Patients Without Nephrectomy and With an Evaluable Primary Renal Tumor in the CheckMate 214 Trial.
Albiges L, Tannir NM, Burotto M, McDermott D, Plimack ER, Barthélémy P, Porta C, Powles T, Donskov F, George S, Kollmannsberger CK, Gurney H, Grimm MO, Tomita Y, Castellano D, Rini BI, Choueiri TK, Leung D, Saggi SS, Lee CW, McHenry MB, Motzer RJ. Albiges L, et al. Among authors: lee cw. Eur Urol. 2022 Mar;81(3):266-271. doi: 10.1016/j.eururo.2021.10.001. Epub 2021 Nov 5. Eur Urol. 2022. PMID: 34750035 Free PMC article. Clinical Trial.
A deadly needle-tract: Inward exsanguination.
Lin CS, Lee CW. Lin CS, et al. Among authors: lee cw. World J Emerg Med. 2022;13(1):74. doi: 10.5847/wjem.j.1920-8642.2022.007. World J Emerg Med. 2022. PMID: 35003422 Free PMC article. No abstract available.
Chronic Sore Throat Mandates Re-Thinking.
Yang SC, Lo SH, Lee CW. Yang SC, et al. Among authors: lee cw. J Emerg Med. 2022 Jan;62(1):e11-e12. doi: 10.1016/j.jemermed.2021.10.024. Epub 2021 Dec 8. J Emerg Med. 2022. PMID: 34893383 No abstract available.
3,076 results